Results of ASCEND-4 trial of ceritinib versus chemotherapy in ALK+ NSCLC patients VJOncology 5:15 7 years ago 153 Далее Скачать
ASCEND-1 and ASCEND-2: Ceritinib for ALK-rearranged NSCLC and baseline brain metastases VJOncology 1:23 8 years ago 85 Далее Скачать
ASCEND-5: Ceritinib for ALK positive NSCLC previously treated with crizotinib ecancer 5:19 7 years ago 240 Далее Скачать
ASCEND-2 and ASCEND-3 trials: Ceritinib in ALK-rearranged NSCLC with brain metastases EMJ 1:04 8 years ago 213 Далее Скачать
Dr. Chow on the Use of Ceritinib in ALK+ NSCLC Metastatic to the Brain OncLive 1:48 5 years ago 244 Далее Скачать
Rationale for Evaluating Ceritinib in ALK-Positive Patients With NSCLC Targeted Oncology 1:16 4 years ago 128 Далее Скачать
ASCEND-8: safety data of ceritinib with or without food in NSCLC ecancer 3:57 5 years ago 66 Далее Скачать
DEBATE: ALK positive NSCLC - Front line therapy - Ceritinib HMP Education 11:38 9 years ago 2 131 Далее Скачать
Options for Upfront Treatment of ALK-Rearranged NSCLC Targeted Oncology 2:03 7 years ago 24 Далее Скачать
Continuation of ceritinib beyond disease progression in ALK-positive NSCLC VJOncology 0:39 8 years ago 148 Далее Скачать
